Mallinckrodt PLC (NYSE:MNK) shares are rocketing a nice 16% after the drug maker unleashed a fourth quarter print that has left Wall Street …
Canaccord’s Neil Maruoka jumps up his price target on VRX, but even with more optimism, still angles for 5% downside potential from the stock.
H.C.
Did an iceberg just wallop into Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock? This biotech company’s shares are plunging at breakneck speed of almost 53%.
Small biotech stocks are often considered “binary” lottery-ticket type events, with either a small chance of big upside, or a much greater probability …
After Roche released initially reassuring datasets for its wet AMD and DME candidate, BTIG’s Dane Leone believes this spells trouble for REGN.
BTIG’s Tim Chiang is out with a bearish case against Teva after last week’s less-than-stellar 2018 guidance reveal.